SharePoint
A- A A+

For Patients & Visitors

Find a Doctor

Find a Doctor

Dr Cinnie Yentia Soekojo

Photo of Dr Cinnie Yentia Soekojo
Credential:
MD, MRCP (UK), FRCPath (UK)
Designation:
Associate Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore

Clinical Lecturer, Yong Loo Lin School of Medicine, National University of Singapore​

Specialty:
Cancer
Sub Specialty:
Haematology-Oncology
Medical and Surgical Conditions:
Blood Cancer, Multiple Myeloma
Special Interest:

General Haematology, Multiple Myeloma, Amyloidosis​

Institution:
National University Cancer Institute, Singapore
National University Health System

Dr Cinnie Yentia Soekojo is an Associate Consultant at the National University Cancer Institute, Singapore. She completed her Internal Medicine residency at the National University Hospital, Singapore and obtained her post-graduate qualification from the Royal Colleges of Physicians, United Kingdom. She continued with her advanced specialty training in Haematology at the National University Cancer Institute, Singapore and obtained her Fellowship of the Royal College of Pathologist, United Kingdom.

Her primary clinical and research interests are in multiple myeloma and plasma cell disorders. She has published in several peer-reviewed journals and has also presented at regional and international meetings. She has received several awards and also holds several grants for her research and is currently involved in clinical trials and translational research in her field of interest.

She is also active in undergraduate teaching and is a Clinical Lecturer at the Yong Loo Lin School of Medicine, National University of Singapore.

Awards and Honours

2018 - Best Oral Presentation, Pitch For Funds Round NLAM Clinician Scientist Unit

2017 - Best Oral Presentation, Singapore Society of Haematology Annual Scientific Meeting

2017 - Best Poster Award (Malignant Haematology), NCIS Annual Research Meeting

Research and Publications

1. Potential clinical application of genomics in multiple myeloma. Soekojo, C. Y., de Mel, S., Ooi, M., Yan, B., & Chng, W. J. (2018). Potential Clinical Application of Genomics in Multiple Myeloma. Int J Mol Sci, 19(6).

2. Role of conventional cytogenetics in myeloma in the era of modern treatment and FISH analysis. Soekojo, C. Y., Wang, G. M., Chen, Y., Casan, J., Wolyncewicz, G., Lin, A., . . . Chng, W. J. (2019). Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis. Clin Lymphoma Myeloma Leuk.

3. Aberrant hyperediting of myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Teoh, PJ, An, O., Chung, T., Chooi, J. Y., Toh, S. H., Fan, S., Wang, W., Koh, B. T., Fullwood, M. J., Ooi, M. G., de Mel, S., Soekojo, C. Y., Chen, L., Ng, S. B., Yang, H., & Chng, W. J. (2018). Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood, 132(12), 1304-1317.

4. Education-based interventions to minimize sampling errors in transfusion. de Mel, S., Lim, S., Soekojo, C. Y., Thow, C., Lang, S.-P., Lee, S.-Y., & Tan, L.-K. (2017). Education-based interventions to minimize sampling errors in transfusion. ISBT Science Series, 12(2), 307-313. 

5. Epicardial and visceral adipose tissue in relation to subclinical atherosclerosis in a Chinese population. Ei Ei Khaing, N., Shyong, T. E., Lee, J., Soekojo, C. Y., Ng, A., & Van Dam, R. M. (2018). Epicardial and visceral adipose tissue in relation to subclinical atherosclerosis in a Chinese population. PLOS ONE, 13(4), e0196328.


Contact

Appt Tel:
Fax:
+65 6777 4413